Company to meet with prospective partners as it accelerates toward IND submission for Telomir-1, with plans to begin human ...

Hovanesian: I would have expected a more rapid uptake of these drugs. The problem was that the first drug approved, Syfovre, had some issues with very rare, but often blinding occlusive vasculitis.

For patients with center-involved diabetic macular edema (CI-DME), lamivudine improves visual acuity, according to a st ...

Hovanesian: It’s a straightforward diagnosis to make when you see the characteristic findings of areas of dropout of retinal pigment epithelium. What’s more important is what we do about it. Often, we ...

Leafy Green VegetablesThink spinach, kale, and collard greens which are rich in lutein and zeaxanthin, antioxidants that ...

The trial will evaluate AXPAXLI in at least 555 patients in a multi-center, double-masked, randomized (2:2:1), 3-arm study.

Roshni Bhat, BS, presented the study on behalf of the Harvard Ophthalmology Metabolomics in Retina (HOMeR) program, which focuses on understanding the mechanisms of AMD progression. The team conducted ...

Essilorluxottica enters the medicine sector and does it by signing an agreement for the acquisition of ophthalmic clinics ...

Looking for eye health support? This IGenics reviews shows how it may boost clarity, night vision & protect from blue light.

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...

An East Tennessee State University researcher will use a $2.6 million grant from the National Institutes of Health to study ...

Number 5: Cimerli offers a promising biosimilar treatment for age-related macular degeneration, enhancing vision preservation ...